Synthetic peptide vaccine confers protection against murine malaria

doi:10.1084/jem.166.5.1591

This Article

Full Text (PDF, 401K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Zavala, F.

Articles by Nussenzweig, V.

Search for Related Content

PubMed

PubMed Citation

Articles by Zavala, F.

Articles by Nussenzweig, V.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Malaria

Social Bookmarking

What's this?

ARTICLES

Synthetic peptide vaccine confers protection against murine malaria

F Zavala, JP Tam, PJ Barr, PJ Romero, V Ley, RS Nussenzweig and V Nussenzweig
Department of Medical and Molecular Parasitology, New York University School of Medicine, New York 10016.

A synthetic peptide, (DPPPPNPN)2D, representing a subunit of the repeat domain of the Plasmodium berghei circumsporozoite protein, was conjugated to tetanus toxoid using bisdiazobenzidine. Immunization of mice and rats with the conjugate induced high serum titers of antibodies to the parasite, and most of the animals were completely protected from malaria infection when challenged with sporozoites.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Kaba, S. A., Brando, C., Guo, Q., Mittelholzer, C., Raman, S., Tropel, D., Aebi, U., Burkhard, P., Lanar, D. E. (2009). A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria. J. Immunol. 183: 7268-7277 [Abstract] [Full Text]
Choi, J.-H., Do, Y., Cheong, C., Koh, H., Boscardin, S. B., Oh, Y.-S., Bozzacco, L., Trumpfheller, C., Park, C. G., Steinman, R. M. (2009). Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. JEM 206: 497-505 [Abstract] [Full Text]
Hutchings, C. L., Birkett, A. J., Moore, A. C., Hill, A. V. S. (2007). Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge. Infect. Immun. 75: 5819-5826 [Abstract] [Full Text]
Calvo-Calle, J. M., Oliveira, G. A., Watta, C. O., Soverow, J., Parra-Lopez, C., Nardin, E. H. (2006). A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge. Infect. Immun. 74: 6929-6939 [Abstract] [Full Text]
Boscardin, S. B., Hafalla, J. C.R., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M., Nussenzweig, R. S., Nussenzweig, M. C. (2006). Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. JEM 203: 599-606 [Abstract] [Full Text]
Billaud, J.-N., Peterson, D., Schodel, F., Chen, A., Sallberg, M., Garduno, F., Goldstein, P., McDowell, W., Hughes, J., Jones, J., Milich, D. (2005). Comparative Antigenicity and Immunogenicity of Hepadnavirus Core Proteins. J. Virol. 79: 13641-13655 [Abstract] [Full Text]
Billaud, J.-N., Peterson, D., Barr, M., Chen, A., Sallberg, M., Garduno, F., Goldstein, P., McDowell, W., Hughes, J., Jones, J., Milich, D. (2005). Combinatorial Approach to Hepadnavirus-Like Particle Vaccine Design. J. Virol. 79: 13656-13666 [Abstract] [Full Text]
Nussenzweig, R. S., Zavala, F. (1997). A Malaria Vaccine Based on a Sporozoite Antigen. NEJM 336: 128-130 [Full Text]
Khusmith, S, Charoenvit, Y, Kumar, S, Sedegah, M, Beaudoin, R., Hoffman, S. (1991). Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252: 715-718 [Abstract]
Etlinger, H., Gillessen, D, Lahm, H., Matile, H, Schonfeld, H., Trzeciak, A (1990). Use of prior vaccinations for the development of new vaccines. Science 249: 423-425 [Abstract]